Serum vitamin E concentration in Iranian population with angiography defined coronary artery disease

Asian Biomedicine

Volumn 6, Issue 1, 2012, Pages 19-25

  Tavallaie, Shima ^a,b   Zobeiri, Mehrnoosh ^a   Haghighat Khazaee, Zohreh ^a   Hassanzadeh Khayyat, Mohammad ^c   Nassirli, Hooriyeh ^d   Malaekeh Nikouei, Bizhan ^d   Sahebkar, Amirhossein ^b   Ghayour Mobarhan, Majid ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Coronary artery disease; HPLC; LDL oxidation; LDL cholesterol; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SMOKING; WAIST HIP RATIO;

EID: 84871644872     PISSN: 19057415     EISSN: 1875855X     Source Type: Journal    
DOI: 10.5372/1905-7415.0601.122     Document Type: Article

References (40)

1. Steinberg D, Lewis A, Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 1997; 95:1062-71. (Pubitemid 27091554)
2. Parks EJ, German JB, Davis PA, et al. Reduced oxidative susceptibility of LDL from patients participating in an intensive atherosclerosis treatment program. Am J Clin Nutr. 1998; 68:778-85. (Pubitemid 28471060)
3. Chan CA. Vitamin E and Atherosclerosis. The Journal of Nutrition. 1998; 128:1593-6.
4. Dutta A, Dutta KS. Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review. Journal of the American College of Nutrition. 2003; 22:258-68. (Pubitemid 36927760)
5. Upston JM, Terentis AC, Stocker R. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential anti-atherogenic supplement. The FASEB Journal. 1999; 13:977-94. (Pubitemid 29249724)
6. Regnstrom J, Nilsson J, Moldeus P, Strom K, Bavenholm P, Tornvall P, Hamsten A. Inverse relation between the concentration of low-density-lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr. 1996; 63:377-85. (Pubitemid 26074699)
7. Gey KF, Pushka P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart diseases in cross cultural epidemiology. Am J Clin Nutr. 1991; 53:326-34.
8. Feki M, Souissi M, Mokhtar E, Hsairi M, Kaabachi N, Antebi H, et al. Vitamin E and coronary heart disease in Tunisians. Clinical Chemistry. 2000; 46:1401-5.
9. Haidari M, Javadi E, Kadkhodaee M, Sanati A. Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. Clinical Chemistry. 2001; 47: 1234-40. (Pubitemid 32579111)
10. Salonen JT, Salonen R, Penttila I, Herranen J, Jauhiainen M, Kantola M. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery diseases. Am J Cardiol. 1985; 56: 226-31. (Pubitemid 15045224)
11. Kok F, De Bruijn AM, Vermeeren R, Hoffman A, Van Laar A, De Bruin M, et al. Serum selenium and vitamin antioxidants and cardiovascular mortality. Am J Clin Nutr. 1987; 45:462-8.
12. Street DA, Comstock GW, Salkled RM, Schüep W, Klag MJ. A population-based case-control study of the association between serum antioxidant and myocardial infarction. Am J Epidemiol. 1991; 134: 719-20.
13. Ohrvall M, Berghund L, Salmmeri I, Lithell H, Aro A, Vessby B. The serum cholesterol and essential fatty acid composition but not alpha tocopherol predicts the development of myocardial infarction in 50-year-old-men: a 9 years follow up. Atherosclerosis. 1996; 127:65-71. (Pubitemid 26425843)
14. Ghayour-Mobarhan M, Sahebkar AH, Livingstone C, Wang T, Lamb D, Ferns G. An investigation of the relationship between serum vitamin E status and coronary risk factors in dyslipidaemic patients. Iranian Journal of Biomedical Science. 2008; 10:206-15.
15. Sarraf-Zadegan N, Seyed-Tabatabaei FA, Bashardoost N, Malek A, Totonchi M, Habibi HR, et al. The prevalence of coronary artery disease in an urban population in Isfahan, Iran. Acta Cardiol. 1999: 54: 257-63. (Pubitemid 29504933)
16. Hatmi ZN, Tahvildari S, Gafarzadeh Motlag A, Sabouri Kashani A. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC cardiovascular Disorder [on line] 2007 [cited 2007]; 7:32, Available from: http://www.biomedcentral.com/1471-2261/7/32.
17. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993; 328:1450-6. (Pubitemid 23143847)
18. Rajasekhar D, Srinivasa Rao P, Latheef S, Saibaba K, Subramanyam G. Association of serum antioxidants and risk of coronary heart disease in South Indian population. Indian Journal of Medical Sciences. 2004; 58:465-71. (Pubitemid 40081884)
19. Salonen JT, Salonen R, Penttila I, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol. 1985; 56:226-31. (Pubitemid 15045224)
20. Kok FJ, de Bruijn AM, Vermeeren R, et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: A 9-year follow-up study in the Netherlands. Am J Clin Nutr. 1987; 45:462-8. (Pubitemid 17020814)
21. Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid soluble antioxidants and coronary heart disease in men. The Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1998; 147:180-6. (Pubitemid 28060490)
22. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y, Bostick RM. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996; 334:1156-62. (Pubitemid 26137974)
23. Pham DQ, Plakogiannis R. Vitamin E supplementation in cardiovascular disease and cancer prevention. The Annals of Pharmacotherapy. 2005; 39:1870-78. (Pubitemid 41527700)
24. Riccioni G, Bucciarelli T, Mancini B, Corradi F, Di Ilio C, Mattei PA, D'Orazio N. Antioxidant Vitamin Supplementation in Cardiovascular Diseases. Annals of Clinical Laboratory Science. 2007; 37:89-95.
25. Schwenke DC, Rudel LL, Sorci-Thomas MG, Thomas MJ. α-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits. Journal of Lipid Research. 2002; 43:1927-38. (Pubitemid 35315811)
26. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999; 354:447-55.
27. Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomized trial in general practice. Lancet 2001; 357:89-95.
28. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342:154-60. (Pubitemid 30051646)
29. Miller III ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Annals of Internal Medicine. 2005; 142: 37-46.
30. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL, Rifai N, Selwyn AP, Creager MA, Ganz P. Long-Term Effect of Combined Vitamins E and C on Coronary and Peripheral Endothelial Function. J Am Coll Cardiol. 2004; 43:629-34. (Pubitemid 38229536)
31. Keith ME, Keith ME, Jeejeebhoy KN, Langer A, Kurian R, Barr A, et al. A controlled clinical trial of vitamin E supplementation in patients with congestive heart failure. Am J Clin Nutr 2001; 73:219-24. (Pubitemid 32109849)
32. Ferns GAA. Multiple step-variable pathway hypothesis: A reason why predictions fail in atherosclerosis. Medical Hypotheses. 2008; 71:923-6.
33. Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 2004; 84:1381-478. (Pubitemid 39302636)
34. Manson JE, Bassuk SS, Stampfer MJ. Does vitamin E supplementation prevent cardiovascular events? J Womens Health (Larchmt). 2003; 12:123-36. (Pubitemid 36546756)
35. Reitman A, Friedrich I, Ben-Amotz A, Levy Y. Low Plasma Antioxidants and Normal Plasma B Vitamins and Homocysteine in Patients with Severe Obesity. IMAJ. 2002; 4:590-3. (Pubitemid 34873766)
36. Brown M. Do vitamin E and fish oil protect against ischemic heart disease? Lancet. 1999; 354:441-2. (Pubitemid 29368917)
37. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Public Health. 1989; 79:158-62. (Pubitemid 19052359)
38. Karajibani M, Hashemi M, Montazerifar F, Bolouri A, Dikshit M.The status of glutathione peroxidase, superoxide desmutase, vitamins A, C, E and malondialdehyde in patients with cardiovascular disease in Zahedan, South Iran. J Nutri Sci Vitaminol. 2009; 55:309-16.
39. Aliabadi M, Kimiagar M, Ghayour-Mobarhan M, Shakeri MT, Nematy M, Ilaty AA, et al. Prevalence of malnutrition in free living elderly people in Iran: a cross-sectional study. Asia Pac J Clin Nutr. 2008; 17:285-9.
40. Palli D, Decarli A, Russo A, Cipriani F, Giacosa A, Amadori D, et al. Plasma levels of antioxidant vitamins and cholesterol in a large population sample in centralnorthern Italy. Eur J Nutr. 1999; 38:90-8. (Pubitemid 29262087)